GD3 (Genesis Drug Discovery & Development) provides contract services to advance NASH research.  All areas of preclinical drug discovery and development are supported including:

  • DMPK/in-vivo Pharmacology and Toxicology
  • Synthetic, Medicinal and Process Chemistry (including IND and IP support)
  • Discovery Biology, Hit to Lead and Lead Optimization
  • Assay and Biomarker development

GD3’s capabilities and expertise also expand to cover a wide range of therapeutic areas including metabolic diseases, oncology, inflammation, autoimmunity and ophthalmology.

Example Resource Snippets x 2

Team Members

Headshot Icon

Profile 1- Name

Profile 1- Job Title

Headshot Icon

Profile 2- Name

Profile 2- Job Title